Tango Therapeutics, Inc. (TNGX)
31.56
+0.63
(+2.04%)
USD |
NASDAQ |
Jun 09, 16:00
31.78
+0.22
(+0.70%)
After-Hours: 20:00
Tango Therapeutics SG&A Expense (Quarterly) : 15.24M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 101.25M |
| Erasca, Inc. | 10.65M |
| Kymera Therapeutics, Inc. | 20.36M |
| NovelStem International Corp. | 0.005M |
| Brainstorm Cell Therapeutics, Inc. | 1.284M |